ArticleActa neuropathologica communications2022

Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study.

Carine Jiguet-Jiglaire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.